iLoF
ILoF is a digital health company pioneering a breakthrough AI-platform to accelerate the future of personalized medicine.
- B2B
- manufacturing
- commission
- health
- health platform
- pharmaceutical
- biotechnology
- big data
- artificial intelligence
- deep learning
- deep tech
- dt and ls
- biotechnology
- horizon europe
- sustainable development goals
- woman founder
- spinout
- core ai
- ai applications
- oncology
- eit ecosystem
- slush24
- drug development
- eit health
- personal health
- nif defense security and resilience
- eit supernovas
- ai drug discovery
- slush23
- tech for biotech and pharma
- techbio
- seal of excellence ec
- eicfund
- digital pharma
- slush22
- photonics tech
- medical diagnostics
- 4yfn 2024
- techbio drug discovery
- precision medicine
- 4yfn 2022
- nif health crisis preparedness
- compbio
- screening
- nif biotech
- alzheimers disease
- wild card (eit health)
- wild card 2019 (eit health)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor investor investor investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
* | N/A | Grant | |
| Total Funding | 000k | ||
Related Content
iLoF, an acronym for "Intelligent Lab on Fiber," is a digital health company that was co-founded by Luís Valente, Mehak Mumtaz, Joana Paiva, and Paula Sampaio.
The company has developed a platform that uses photonics and artificial intelligence to create a cloud-based library of optical fingerprints. This technology is designed for non-invasive tracking, screening, and stratification of patients for clinical trials, with an initial focus on Alzheimer's disease. The platform aims to accelerate drug discovery and make clinical trials more efficient and less costly.
iLoF's business model is centered on providing its platform to pharmaceutical companies and research institutions to improve the patient selection process for clinical trials. By identifying suitable candidates more accurately, the company helps to reduce the high failure rates associated with these trials.
The company has received funding from several notable investors, including EIT Health, Faber, M12 (Microsoft's venture fund), and Mayfield. It was also the Global Deep Tech winner of the Female Founders Competition, backed by M12, Mayfield, and Melinda Gates' Pivotal Ventures.
Keywords: digital health, biotech, artificial intelligence, photonics, drug discovery, clinical trials, personalized medicine, Alzheimer's disease, biomarkers, patient stratification